+ Watch ONVO
on My Watchlist
ONVO is a market leader in 3d printing live tissue. I beleive they will continue to make headway into the healthcare and pharmaceutical market, but the company has a long way to go. There are still risks will the current price, but if they continue to innovate and show everyone they can deliver a profitable product, the share price should see significant price appreciation.
I've spent several hours reading the short reports and the hype articles. This company, formerly known as Real Estate Restoration and Rental Inc., just doesn't smell right. I encourage you to dig into the SEC filings or watch one of the company's promotional videos. The videos remind me of a community college commercial from the eighties. Given the current stock valuation, I was expecting to watch a 3D printing of a Darth Vader arm, or even a pinky finger. But to my dismay, all I got was cheesy music and a technician holding what looked to be pink slime in a test tube. Perhaps, betting on company that spends three times the money on stock promotion consultants than on R&D, works in CAPS; however, I am with the bears on this one. JUNK
3D ORGAN Developement has huge potential for medical health.
Still believe it's a good niche area for this technology, the company seems to be making critical collaborations work. Any technology that can accelerate the drug discovery process is going to succeed.
This is bleeding edge technology that combines the paradigm shift of 3D printing with bio-medical science. They have real products, but are not yet in manufacturing mode. This is one of two equities I decided would comprise my more potential than tangible products slice of the pie.
Limited market for liver assay product, and will compete with established players. Potential market of (optimistically) a few million dollars a year does not justify a nearly billion-dollar market cap. Other products still in the far future. Management enthusiastically selling shares at these prices.
Very promising field...
3d printing organs, cool!
The long term possibilities of this cutting edge company are high, but so are the risks. However, I still like the companies model.
Though I doubt much profit to be reaped in the first few years, I think the ideas and the technology that this company will develop will be well worth the wait.
ONVO is about as disruptive a technology as it gets: 3-D printing combined with biomedical science.
Boiler room, they don't print s**t !
It prints Organs, very useful for the aging population. can anyone say GOD?
The future that now seems like science fiction.
3D printed livers baby!
Expecting the speculation to be heavy and positive on ONVO in Q1 and Q2 2014. Ride the 3D momentum on the edge.
Their trademark could give them control of this market.
This company has what seems to be a foot in the door of a very lucrative market. The organs that the print can have a huge impact on the future health of the world. Testing drugs on live tissues that can be reproduced at will, will increase the rate and effectiveness of pharmacalogical research. This company may even be able to print "New" organs for those who have failing ones.This technology still needs to be proven a little bit but I have a decent position in this slightly speculative stock.
Has a lot going for it...20-25 by end of 2014.
After their 3 D Liver they will develope a 3 D Heart.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions